Compare · MDLN vs TCMD
MDLN vs TCMD
Side-by-side comparison of Medline Inc. (MDLN) and Tactile Systems Technology Inc. (TCMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and TCMD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 91.1x TCMD ($527.6M).
- MDLN has hit the wire 7 times in the past 4 weeks while TCMD has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 9 for TCMD).
- Company
- Medline Inc.
- Tactile Systems Technology Inc.
- Price
- -
- -
- Market cap
- $48.08B
- $527.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2016
- News (4w)
- 7
- 0
- Recent ratings
- 25
- 9
Tactile Systems Technology Inc.
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; and Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M
Latest TCMD
- Amendment: SEC Form SCHEDULE 13G/A filed by Tactile Systems Technology Inc.
- Chief Executive Officer Dodd Sheri Louise sold $323,243 worth of shares (10,978 units at $29.44), decreasing direct ownership by 5% to 232,907 units (SEC Form 4)
- SEC Form 10-Q filed by Tactile Systems Technology Inc.
- Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results
- Tactile Systems Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026
- Tactile Systems Technology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients
- Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy
- Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference